115 related articles for article (PubMed ID: 21275434)
1. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; Waked I; Khan SA; Taylor-Robinson SD
J Proteome Res; 2011 Apr; 10(4):1828-36. PubMed ID: 21275434
[TBL] [Abstract][Full Text] [Related]
2. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
4. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
5. Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.
Shariff MI; Ladep NG; Cox IJ; Williams HR; Okeke E; Malu A; Thillainayagam AV; Crossey MM; Khan SA; Thomas HC; Taylor-Robinson SD
J Proteome Res; 2010 Feb; 9(2):1096-103. PubMed ID: 19968328
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.
Osman D; Ali O; Obada M; El-Mezayen H; El-Said H
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27862090
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabolite variation is associated with pathological progression of the post-hepatitis B cirrhosis patients.
Wang X; Wang X; Xie G; Zhou M; Yu H; Lin Y; Du G; Luo G; Jia W; Liu P
J Proteome Res; 2012 Jul; 11(7):3838-47. PubMed ID: 22624806
[TBL] [Abstract][Full Text] [Related]
8. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection diagnosis using metabonomics.
Godoy MM; Lopes EP; Silva RO; Hallwass F; Koury LC; Moura IM; Gonçalves SM; Simas AM
J Viral Hepat; 2010 Dec; 17(12):854-8. PubMed ID: 20070502
[TBL] [Abstract][Full Text] [Related]
10. Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
Tamura S; Fujioka H; Nakano T; Amuro Y; Hada T; Nakao N; Higashino K
Am J Gastroenterol; 1988 Aug; 83(8):841-5. PubMed ID: 2456010
[TBL] [Abstract][Full Text] [Related]
11. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy.
Wei L; Liao P; Wu H; Li X; Pei F; Li W; Wu Y
Toxicol Appl Pharmacol; 2009 Feb; 234(3):314-25. PubMed ID: 19073202
[TBL] [Abstract][Full Text] [Related]
13. Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.
Ye G; Zhu B; Yao Z; Yin P; Lu X; Kong H; Fan F; Jiao B; Xu G
J Proteome Res; 2012 Aug; 11(8):4361-72. PubMed ID: 22768978
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
15. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-related transforming growth factors in the urine of patients with hepatocellular carcinoma.
Chuang LY; Tsai JH; Yeh YC; Chang CC; Yeh HW; Guh JY; Tsai JF
Hepatology; 1991 Jun; 13(6):1112-6. PubMed ID: 1646759
[TBL] [Abstract][Full Text] [Related]
17. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
18. Patterns of excretion of methylated purines in hepatocellular carcinoma.
Ho Y; Lin HJ
Cancer Res; 1974 May; 34(5):986-90. PubMed ID: 4363066
[No Abstract] [Full Text] [Related]
19. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
20. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
Azzaroli F; Colecchia A; Lodato F; Trerè D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
Aliment Pharmacol Ther; 2006 Jul; 24(1):129-36. PubMed ID: 16803611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
